iToxi Sets Rights Issue Price at KRW 500 (Face Value) Amid Trading Suspension
iToxi (KOSDAQ-listed) confirmed the issue price of new shares at KRW 500 (face value) in a correction filing on May 12, 2026, for its rights offering.
Trading has been suspended since March 23, 2026; no market price formed during the 3-5 trading days before the subscription date (May 14).
Last closing price before suspension was KRW 312, but issuance below face value is prohibited under the Commercial Act (Article 330), leading to a price of KRW 500.
All new shares will be deposited with the Korea Securities Depository for a 6-month lock-up period.
The offering is a third-party allocation; specific target entities and fund usage details are not disclosed.
KOSDAQ Filing Information
Filing: [Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)